This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
LifeSpan Biosciences
product type :
protein
product name :
Human PPM1F Protein (Recombinant His) - LS-G5503
catalog :
LS-G5503
product information
ProteinId :
5503
CatalogNumber :
LS-G5503
Product Name :
Human PPM1F Protein (Recombinant His) - LS-G5503
PresentationDesc :
20 mM Tris-HCl, pH 8.0, 20% glycerol, 150 mM NaCl, 1 mM DTT
ProteinTag :
His
ProteinType :
Recombinant
ProteinSpecies :
Human
ProteinSourceSpecies :
E. coli
RecommendedStorage :
Store at -20°C. Avoid freeze-thaw cycles.
Purification :
Greater than 90% by SDS-PAGE
PredictedMolecularWeight :
52 kDa
Gene :
PPM1F
StandardGeneSymbol :
PPM1F
Subfamily :
PP2C
gene family :
Protein Phosphatase
Synonyms :
PPM1F, CAMKP, CaMKPase, FEM-2, PP2C phosphatase, Protein fem-2 homolog, Protein phosphatase 1F, POPX2, CaM-kinase phosphatase, HFEM-2, KIAA0015, Partner of PIX 2
ShippingInstruction :
+4°C Ice Packs
SalesRegion :
Worldwide
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
Seattle, WA 98121
CustomerSupport@lsbio.com
https://www.lsbio.com1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.
questions and comments